PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97673825 |
Filing Date: 11/11/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97673825 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\976\738\97673825\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | INGREZZA |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) pink, orange, white, and black is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of a sequence of right pointing arrows colored pink on the left shading into orange outlined with white lines and the word "INGREZZA" in black. The other white in the mark is background and is not claimed as a feature. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 816 x 255 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Neurocrine Biosciences, Inc. |
*MAILING ADDRESS | 12780 El Camino Real |
*CITY | San Diego |
*STATE (Required for U.S. applicants) |
California |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
92130 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations for human use for schizophrenia, adjunctive treatment of schizophrenia, schizoaffective disorder, bipolar disorder, bipolar mania, DiGeorge syndrome, Lesch-Nyhan syndrome, and movement disorders, namely, Myoclonus, chorea associated with Huntington's Disease, Levodopa-induced dyskinesia, dyskinetic cerebral palsy, dystonia, and tics. |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | B. Brett Heavner |
ATTORNEY DOCKET NUMBER | 14640.1013 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Finnegan, Henderson, Farabow, Garrett & Dunner LLP |
STREET | 901 New York Avenue NW |
CITY | Washington |
STATE | District of Columbia |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 20001 |
PHONE | 202-408-4000 |
FAX | 202-408-4400 |
EMAIL ADDRESS | docketing@finnegan.com |
OTHER APPOINTED ATTORNEY | all the other attorneys of Finnegan, Henderson, Farabow, Garrett & Dunner LLP |
CORRESPONDENCE INFORMATION | |
NAME | B. Brett Heavner |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | docketing@finnegan.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | teas-filing-receipts@finnegan.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /David L. Bradfute/ |
SIGNATORY'S NAME | David L. Bradfute, PhD, JD |
SIGNATORY'S POSITION | Vice President & Head, Intellectual Property |
SIGNATORY'S PHONE NUMBER | 202-408-4000 |
DATE SIGNED | 11/11/2022 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97673825 |
Filing Date: 11/11/2022 |
The applicant's current Correspondence Information: |
B. Brett Heavner |
PRIMARY EMAIL FOR CORRESPONDENCE: docketing@finnegan.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): teas-filing-receipts@finnegan.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|